The Varian Ethos 2.0 technology is part of UH's broader cancer care initiative, which includes a new $39 million regional ...

A team of researchers at the University of Minnesota recently completed a human trial for a novel gene-editing treatment, ...

Patients with metastatic colorectal cancer who were treated with a biweekly dose of trifluridine-tipiracil (TAS-102) saw ...

Fecal microbiota transplants (FMT) have been touted as a potential treatment for a variety of conditions, from inflammatory ...

T-cell therapy has shown remarkable clinical efficacy in haematological malignancies, currently representing a well ...

For the first time in years, small cell lung cancer (SCLC) patients have reason for renewed hope as more treatment options ...

Patients with metastatic colorectal cancer who were treated with a biweekly dose of trifluridine-tipiracil (TAS-102) saw ...

For the first time, a medicine aimed directly at the HER2 protein improved overall survival after gastric cancer progressed ...

A study led by Cancer Center at Illinois (CCIL) member Jason Ridlon, associate professor of animal sciences in the College of ...